Calgary, Alberta – TheNewswire - September 15, 2022 - nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) announces that the initial marketing campaign ("Campaign") for it's advanced YMI mental health platform has progressed to the implementation stage. The Campaign is focused on the Canada-wide market and expected to run over the next few months. The Campaign was designed to test the effectiveness of a variety of marketing channels such as social media, search, display, video and native ads. Coincident with the Campaign, the Corporation will refine it's referral programs involving both the consumer mHealth market and the "B2B" psychotherapist market. It is expected that initial revenues will be achieved before the end of the year in advance of the refined release of YMI into the US market. The Campaign is fully funded by the Corporation's existing cash balance.

NDAT's President Jim Durward states: "With the YMI platform being fully functional, the marketing strategy set, and mental health remaining a top concern of the general public, we believe this is a "right place at the right time" scenario. Now is the time to execute."

YMI is available now at https://ymihealth.ca/

About nDatalyze Corp.:

nDatalyze Corp. generates technology-based, health-related solutions. The YMI division is developing a machine-learning based, online consumer mental health application with it's database licensing division focusing on providing a specialized health-related Reference Database to application developers and researchers. YMI is based on the Corporation's proprietary Reference Database consisting of >1200 biometric records complete with associated electroencephalogram ("EEG") data. With installations worldwide, it's Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI is in development and accordingly the Corporation cannot accurately predict if or when this application will become a cash flow generator.

FOR FURTHER INFORMATION, PLEASE CONTACT:

nDatalyze Corp.

James Durward, President and CEO

Telephone: (403) 689-3901

Email: jimd@ndatalyze.com     Website: www.ndatalyze.com  

Investor Relations

RBMG - RB Milestone Group LLC

ndatalyze@rbmilestone.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.